Beyond aerobic glycolysis : Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis,Anthony A. Mancuso,Evgueni Daikhin,Ilana Nissim,Marc Yudkoff,Suzanne Wehrli,Craig B. Thompson +6 more
TLDR
Transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools, and glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.Abstract:Â
Tumor cell proliferation requires rapid synthesis of macromolecules including lipids, proteins, and nucleotides. Many tumor cells exhibit rapid glucose consumption, with most of the glucose-derived carbon being secreted as lactate despite abundant oxygen availability (the Warburg effect). Here, we used 13C NMR spectroscopy to examine the metabolism of glioblastoma cells exhibiting aerobic glycolysis. In these cells, the tricarboxylic acid (TCA) cycle was active but was characterized by an efflux of substrates for use in biosynthetic pathways, particularly fatty acid synthesis. The success of this synthetic activity depends on activation of pathways to generate reductive power (NADPH) and to restore oxaloacetate for continued TCA cycle function (anaplerosis). Surprisingly, both these needs were met by a high rate of glutamine metabolism. First, conversion of glutamine to lactate (glutaminolysis) was rapid enough to produce sufficient NADPH to support fatty acid synthesis. Second, despite substantial mitochondrial pyruvate metabolism, pyruvate carboxylation was suppressed, and anaplerotic oxaloacetate was derived from glutamine. Glutamine catabolism was accompanied by secretion of alanine and ammonia, such that most of the amino groups from glutamine were lost from the cell rather than incorporated into other molecules. These data demonstrate that transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools. Rather, glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.read more
Citations
More filters
Journal ArticleDOI
Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors.
TL;DR: To define the reciprocal metabolic interplay between CAFs and cancer cells will provide a better understanding of molecular mechanisms by which the treatment resistance occurs, and aid in the rational design of metabolism-based approaches to enhance the efficacy of immunotherapy.
Journal ArticleDOI
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Weiqi Dai,Ling Xu,Xiang-Nan Yu,Guang-Cong Zhang,Hong-Ying Guo,Hailin Liu,Guangqi Song,Shuqiang Weng,Ling Dong,Ji-Min Zhu,Tao-Tao Liu,Chuanyong Guo,Xizhong Shen,Xizhong Shen +13 more
TL;DR: Investigating the role of oxoglutarate dehydrogenase-like (OGDHL), one of the rate-limiting components of the key mitochondrial multi-enzyme OGDH complex, in the regulation of lipid metabolism in hepatoma cells and exploring the underlying molecular mechanisms established that silencing of OGDHL contributed to HCC development and survival by regulating glutamine metabolic pathways.
Journal ArticleDOI
Novel drugs that target the metabolic reprogramming in renal cell cancer
Johannes C. van der Mijn,Johannes C. van der Mijn,David J. Panka,Andrew K Geissler,Henk M.W. Verheul,James W. Mier +5 more
TL;DR: A detailed overview of the metabolic changes in RCC is presented in conjunction with potential novel therapeutics and preclinical studies that have investigated targeted agents that interfere with various aspects of tumor cell metabolism are discussed.
Journal ArticleDOI
Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up
Ahmed M. A. Elsakka,Mohamed Abdel Bary,Eman Abdelzaher,Mostafa Elnaggar,Miriam Kalamian,Purna Mukherjee,Thomas N. Seyfried +6 more
TL;DR: This is the first report of confirmed GBM treated with a modified SOC together with KMT and HBOT, and other targeted metabolic therapies and additional studies are needed to validate the efficacy of KMT administered with alternative approaches that selectively increase oxidative stress in tumor cells while restricting their access to glucose and glutamine.
Journal ArticleDOI
Importance of Glutamine Metabolism in Leukemia Cells by Energy Production Through TCA Cycle and by Redox Homeostasis
Mineaki Goto,Hiroshi Miwa,Masato Shikami,Norikazu Tsunekawa-Imai,Kazuto Suganuma,Shohei Mizuno,Miyuki Takahashi,Motonori Mizutani,Ichiro Hanamura,Masakazu Nitta +9 more
TL;DR: Growth of HL-60 cells was most suppressed by glutamine deprivation and by inhibition of glutaminolysis, which was rescued by tricarboxylic acid (TCA) cycle intermediate, oxaloacetic acid.
References
More filters
Journal ArticleDOI
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
TL;DR: Observations suggest that glutamine provides energy by aerobic oxidation from citric acid cycle metabolism, provides more than half of the cell energy when high concentrations of glucose are present, and greater than 98% when fructose or galactose is the carbohydrate.
Journal ArticleDOI
ATP citrate lyase inhibition can suppress tumor cell growth
Georgia Hatzivassiliou,Fangping Zhao,Daniel E. Bauer,Charalambos Andreadis,Shaw Antony N,Dashyant Dhanak,Sunil R. Hingorani,David A. Tuveson,Craig B. Thompson +8 more
TL;DR: ACL inhibition by RNAi or the chemical inhibitor SB-204990 limits in vitro proliferation and survival of tumor cells displaying aerobic glycolysis, and these treatments also reduce in vivo tumor growth and induce differentiation.